Jacobson Allan's Insider Trades & SAST Disclosures
Jacobson Allan's most recent trade in PTC Therapeutics Inc was a trade of 1,230 Common Stock done at an average price of $51.5 . Disclosure was reported to the exchange on March 4, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jacobson Allan.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| PTC Therapeutics Inc | Allan Jacobson | Director | Sale of securities on an exchange or to another person at price $ 51.52 per share. | 04 Mar 2025 | 1,230 | 19,118 (0%) | 0% | 51.5 | 63,370 | Common Stock |
| PTC Therapeutics Inc | Allan Jacobson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 8,800 | 8,800 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Allan Jacobson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 4,000 | 20,348 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Jacobson Allan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Jacobson Allan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 4,000 | 16,348 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Jacobson Allan | Director | Sale of securities on an exchange or to another person at price $ 27.38 per share. | 22 Jan 2024 | 10,000 | 12,348 (0%) | 0% | 27.4 | 273,804 | Common Stock |
| PTC Therapeutics Inc | Allan Jacobson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2024 | 10,000 | 0 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Jacobson Allan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.05 per share. | 22 Jan 2024 | 10,000 | 22,348 (0%) | 0% | 27.1 | 270,500 | Common Stock |
| PTC Therapeutics Inc | Allan Jacobson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2023 | 23,000 | 0 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Allan Jacobson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.85 per share. | 11 May 2023 | 23,000 | 35,348 (0%) | 0% | 10.9 | 249,550 | Common Stock |
| PTC Therapeutics Inc | Allan Jacobson | Director | Sale of securities on an exchange or to another person at price $ 54.78 per share. | 11 May 2023 | 19,040 | 16,308 (0%) | 0% | 54.8 | 1,043,074 | Common Stock |
| PTC Therapeutics Inc | Allan Jacobson | Director | Sale of securities on an exchange or to another person at price $ 56.35 per share. | 11 May 2023 | 2,860 | 13,448 (0%) | 0% | 56.4 | 161,169 | Common Stock |
| PTC Therapeutics Inc | Allan Jacobson | Director | Sale of securities on an exchange or to another person at price $ 56.99 per share. | 11 May 2023 | 1,100 | 12,348 (0%) | 0% | 57.0 | 62,687 | Common Stock |
| PTC Therapeutics Inc | Allan Jacobson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Allan Jacobson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 4,000 | 12,348 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Allan Jacobson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 12,000 | 12,000 | - | - | Stock Option (Right To Buy) | |
| PTC Therapeutics Inc | Allan Jacobson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 3,200 | 8,348 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Allan Jacobson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2021 | 10,000 | 10,000 | - | - | Stock Option (Right To Buy) | |
| PTC Therapeutics Inc | Allan Jacobson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2021 | 1,650 | 5,148 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Allan Jacobson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Nov 2020 | 20,000 | 23,000 | - | - | Stock Option (Right To Buy) | |
| PTC Therapeutics Inc | Allan Jacobson | Director | Sale of securities on an exchange or to another person at price $ 60.00 per share. | 04 Nov 2020 | 20,000 | 3,498 (0%) | 0% | 60 | 1,200,000 | Common Stock |
| PTC Therapeutics Inc | Allan Jacobson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.85 per share. | 04 Nov 2020 | 20,000 | 23,498 (0%) | 0% | 10.9 | 217,000 | Common Stock |
| PTC Therapeutics Inc | Allan Jacobson | Director | Sale of securities on an exchange or to another person at price $ 51.29 per share. | 16 Oct 2020 | 5,000 | 3,498 (0%) | 0% | 51.3 | 256,450 | Common Stock |
| PTC Therapeutics Inc | Allan Jacobson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2020 | 17,900 | 43,000 | - | - | Stock Option (Right To Buy) | |
| PTC Therapeutics Inc | Allan Jacobson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.85 per share. | 17 Apr 2020 | 17,900 | 26,398 (0%) | 0% | 10.9 | 194,215 | Common Stock |
| PTC Therapeutics Inc | Allan Jacobson | Director | Sale of securities on an exchange or to another person at price $ 51.41 per share. | 17 Apr 2020 | 9,653 | 8,598 (0%) | 0% | 51.4 | 496,299 | Common Stock |
| PTC Therapeutics Inc | Allan Jacobson | Director | Sale of securities on an exchange or to another person at price $ 50.58 per share. | 17 Apr 2020 | 8,147 | 18,251 (0%) | 0% | 50.6 | 412,043 | Common Stock |
| PTC Therapeutics Inc | Allan Jacobson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2020 | 2,100 | 60,900 | - | - | Stock Option (Right To Buy) | |
| PTC Therapeutics Inc | Allan Jacobson | Director | Sale of securities on an exchange or to another person at price $ 50.16 per share. | 17 Apr 2020 | 2,100 | 8,498 (0%) | 0% | 50.2 | 105,332 | Common Stock |
| PTC Therapeutics Inc | Allan Jacobson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.85 per share. | 17 Apr 2020 | 2,100 | 10,598 (0%) | 0% | 10.9 | 22,785 | Common Stock |
| PTC Therapeutics Inc | Allan Jacobson | Director | Sale of securities on an exchange or to another person at price $ 52.16 per share. | 17 Apr 2020 | 100 | 8,498 (0%) | 0% | 52.2 | 5,216 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges